Brookfield Asset Management

The Scandium Scare Short sellers are targeting Bloom Energy again, sending the stock down 20%. The bear case centers on scandium, a rare-earth element critical for Bloom’s solid oxide fuel cell technology. Critics claim Bloom lacks the scandium supply to scale, implying the company is an AI-cycle illusion. Tech Titans Do Their Homework To believe the short thesis, you must believe that multi-billion-dollar titans lack basic diligence. Brookfield recently expanded its partnership with Bloom to $25 billion, Nebius committed $2.6 billion, and Oracle contracted for up to 2.8 gigawatts of power. These tech giants do not sign massive, multi-decade infrastructure commitments on a whim. They verified the supply chains before committing capital. SEC Filing Clarifies Supply Bloom fired back with an SEC filing confirming sufficient non-China scandium supply for its entire backlog and current demand. The company claims visibility into 25 gigawatts of annual production. Crucially, the critics’ math fails because they lack proprietary data on Bloom’s material intensity and manufacturing efficiency gains. Systemic Delays Are Not Company Failures Critics point to data center construction delays as a red flag. This argument is disingenuous. Every major player building out AI infrastructure faces grid connection and construction delays. It is a systemic issue, not a unique failure of Bloom’s technology. The Final Verdict This panic is a classic recycling of old rumors, presenting a compelling buying opportunity. While the short seller may genuinely believe their thesis, the risk-reward profile strongly favors holding or accumulating shares. Trust the data and the tech partners’ deep pockets over speculative short reports.